Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
113 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Bio Wink from Brussel, company number BE0736308291, closed financial year 2025 with a result of € 11,659 after tax. For that financial year Bio Wink recorded a gross margin of € 21,977 and equity of € 38,779. Compared with financial year 2024, the result moved from € 48,576 to € 11,659. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 28, 2026.
€ 38,779
▲ 40% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 11,659
▼ 76% vs 2024
Profit after tax over the fiscal year.
€ 15,935
▼ 77% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 20,779.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 15,553
▼ 83% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,836
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 6,523 | € 54,793 | € 57,907 | € 21,977 | ▼ 62% |
| Profit after taxes | € -21,494 | € -9,260 | € 48,576 | € 11,659 | ▼ 76% |
| Equity | € -2,197 | € -11,957 | € 27,620 | € 38,779 | ▲ 40% |
| Total debts | € 140,918 | € 125,278 | € 194,828 | € 67,735 | ▼ 65% |
| Cash | - | € 9,218 | € 69,802 | € 15,935 | ▼ 77% |
| Retained profit | € -30,197 | € -39,457 | € 9,120 | € 20,779 | ▲ 128% |
| Balance sheet total | € 138,721 | € 113,321 | € 222,448 | € 106,514 | ▼ 52% |
| Employees (FTE) | 1.9 | 1.2 | - | - |
Key figures of Bio Wink, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to Bio Wink?
What happened at Bio Wink in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 11,659 (▼ 76% vs 2024). Source: NBB ↗
- New establishment in Watermaal-Bosvoorde. KBO
- INTERCONCEPT SRL became a director. NBB
- IC PHARMA SRL became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 21,494 loss in 2022 to € 11,659 profit in 2025.
Paid € 9,887 in corporate taxes since 2022.
Best year ever: 2024, with € 48,576 profit.
On average € 45,700 of value added per employee in 2023.
A new publication or filing at Bio Wink? We notify you, reason included.
Follow Bio WinkDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of IC PHARMA DISTRIBUTION, IC PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Bio WinkBehind Bio Wink are INTERCONCEPT SRL, IC PHARMA SRL and IC PHARMA DISTRIBUTION SRL. The shares are held by IC PHARMA DISTRIBUTION (1%) and IC PHARMA (0.3%).
Directors
According to the 2025 annual accounts
Director · represented by Jean-Baptiste VAN HAMME
Also active at: BENCH SYSTEM, IC PHARMA DISTRIBUTION, IC PHARMA, COSMEX
since 2019
Director · represented by Tangie LE GALL
since 2019
Director · represented by Jean-Baptiste VAN HAMME
Shareholders
0.3%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Congresstraat 35
1000 Brussel
Terhulpsesteenweg 177 box 20
1170 Watermaal-Bosvoorde
Active since 11 October 2019
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 113 companies are registered at this address.
All companies at this address →Caisse d'Entraide de Prêts et de Financements
€ 19,883 gross margin · 2024
Société pour la Production et le commerce de Dérivés organiques
ISS FACILITY SERVICES
€ 350.1 million revenue · 2025
NERM
€ 20,430 gross margin · 2025
ISS CATERING
€ 106.8 million revenue · 2025
+108 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0736.308.291
- VAT number
- BE 0736.308.291
- Registered office
- Congresstraat 35, 1000 Brussel
- Names & denominations
- Bio Wink
- Enterprise type
- Rechtspersoon
- Legal form
- Cooperative company
- Legal situation
- Normale toestand
- Start date
- 11 October 2019
- Peppol
- Active · Active since 6 Nov 2025
- Contact
- [email protected]
- Activities · NACE
Groothandel in farmaceutische en medische artikelen